TARGETING FLT3 WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS CONFERS POTENT REACTIVITY AGAINST ACUTE MYELOID LEUKEMIA (AML)

EHA Library, HARDIKKUMAR JETANI, 181432

A NOVEL MODEL OF HUMAN LYMPHO-MYELOID PROGENITOR HIERARCHY BASED ON SINGLE CELL FUNCTIONAL AND TRANSCRIPTIONAL ANALYSIS

EHA Library, Dimitrios Karamitros, 181427

METABOLIC ADAPTATIONS TO TARGETED THERAPY IN FLT3 MUTATED ACUTE MYELOID LEUKAEMIA (AML)

EHA Library, Paolo Gallipoli, 181423

DEFINITION OF PARTIAL RESPONSE IN YOUNGER AML PATIENTS AFTER FIRST INDUCTION COURSE MAY BE EXTENDED BY INCLUSION OF IMMUNOPHENOTYPIC DETECTION OF MEASURABLE RESIDUAL DISEASE IN CR

EHA Library, Sylvia Freeman, 181401

CD34+ AND HUMAN INDUCED PLURIPOTENT STEM CELL (IPSC) DIFFERENTIATION TO TRANSFUSION READY RED BLOOD CELLS

EHA Library, Marie-Jose Claessen, 181419

THERAPEUTIC DISRUPTION OF THE BAFF- B-CELL RECEPTOR (BCR) CROSS-TALK IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS

EHA Library, Alexey Danilov, 181405

TRANSCRIPTOME SEQUENCING REVEALS DISTINCT SUBTYPES OF MYELODYSPLASIA WITH PROGNOSTIC SIGNIFICANCE

EHA Library, Seishi Ogawa, 181410

DELETION OF THE F-BOX PROTEIN NIPA (NUCLEAR INTERACTION PARTNER OF ALK) IMPAIRS NPM-ALK DRIVEN TRANSFORMATION

EHA Library, Lena Johanna Lippert, 181414

FIRST EVIDENCE DEMONSTRATING ENGRAFTMENT AND REPOPULATION ADVANTAGE OF GENE-CORRECTED HEMATOPOIETIC REPOPULATING CELLS IN NON-CONDITIONED FANCONI ANEMIA PATIENTS

EHA Library, Julián Sevilla, 181431

PHASE I, OPEN-LABEL TRIAL OF ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR T CELLS IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA

EHA Library, Wanggang Zhang, 181390

ANALYSIS AND CHARACTERIZATION OF HEMATOLOGIC CANCERS USING A COMPREHENSIVE NGS PANEL COMPRISED OF DNA AND RNA BAITS TARGETING 704 GENES

EHA Library, Timothy Stenzel, 181395

SHORT-TERM FEEDING OF A HIGH-FAT DIET DISTURBS LIPID RAFT/TGF-ΒETA SIGNALING-MEDIATED QUIESCENCE OF HEMATOPOIETIC STEM CELLS IN C57BL/6J MOUSE BONE MARROW

EHA Library, François Hermetet, 181426

LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY

EHA Library, W Zeijlemaker, 181400

INHIBITION OF THE MYELOID MASTER REGULATOR PU.1 AS A THERAPEUTIC STRATEGY IN ACUTE MYELOID LEUKEMIA

EHA Library, Ileana Antony-Debre, 181422

INTEGRATIVE ANALYSIS OF THE GENOME, EPIGENOME, TRANSCRIPTOME AND THREE-DIMENSIONAL CHROMATIN STRUCTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Renée Beekman, 181404

LONG-TERM HEALTH STATUS AFTER HSC TRANSPLANTATION FOR THALASSEMIA: THE FRENCH EXPERIENCE

EHA Library, isabelle Thuret, 181418

IDENTIFICATION OF ABERRANTLY SPLICED GENES AND DEREGULATED PATHWAYS/GENE ONTOLOGY THEMES IN MYELODYSPLASTIC SYNDROME PATIENTS WITH SPLICING FACTOR GENE MUTATIONS

EHA Library, Andrea Pellagatti, 181409

ALPHA-KETOGLUTURATE EXPOSES METABOLIC VULNERABILITIES IN B-CELL LYMPHOMAS

EHA Library, Ricardo Aguiar, 181413

MINIMAL RESIDUAL DISEASE (MRD) BY MULTIPARAMETER FLOW CYTOMETRY (MFC) IN TRANSPLANT ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (MM): RESULTS FROM THE EMN02/HO95 PHASE 3 TRIAL

EHA Library, Stefania Oliva, 181389

BASELINE AND EARLY POST-TREATMENT CLINICAL AND LABORATORY FACTORS ASSOCIATED WITH SEVERE NEUROTOXICITY FOLLOWING 19-28Z CAR T CELLS IN ADULT PATIENTS WITH RELAPSED B-ALL

EHA Library, Eric Smith, 181430

RITUXIMAB SC AND IV PLUS CHOP SHOW SIMILAR EFFICACY AND SAFETY IN THE RANDOMIZED MABEASE STUDY IN FIRST-LINE DLBCL

EHA Library, Pieternella (Elly) Lugtenburg, 181394

GRAFT VERSUS LEUKEMIA EFFECT OF ALLOGENEIC STEM CELL TRANSPLANTATION AND MINIMAL RESIDUAL DISEASE IN PATIENTS WITH AML IN FIRST COMPLETE REMISSION.

EHA Library, Jurjen Versluis, 181399

DENOSUMAB INCREASES BONE MINERAL DENSITY IN PATIENTS WITH THALASSEMIA MAJOR AND OSTEOPOROSIS: RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE BLIND, PHASE 2B CLINICAL TRIAL

EHA Library, Ersi Voskaridou, 181417

THE VALUE OF NGS PANEL SEQUENCING TO MOLECULARLY DEFINE MYELOID MALIGNANCIES AND CLARIFY BORDERLINE CASES: A STUDY ON 39 GENES IN 1143 PATIENTS

EHA Library, Constance Baer, 181408

FOXO1 CONTROL CD20 EXPRESSION AND INFLUENCE B-CELL LYMPHOMA RESPONSE TO RITUXIMAB-BASED IMMUNOTHERAPY

EHA Library, Michal Dwojak, 181412

GENETIC ALTERATIONS INVOLVING PROGRAMMED DEATH LIGANDS IN EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOMAS

EHA Library, Keisuke Kataoka, 181411

GENE THERAPY FOR BETA THALASSEMIA: INITIAL RESULTS FROM THE PHASE I/II TIGET-BTHAL TRIAL OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS GENETICALLY MODIFIED WITH GLOBE LENTIVIRAL VECTOR

EHA Library, Sarah Marktel, 181415

LUSPATERCEPT INCREASES HEMOGLOBIN AND DECREASES TRANSFUSION BURDEN IN ADULTS WITH Β-THALASSEMIA

EHA Library, Antonio Piga, 181416

A NOVEL GENETIC AND MORPHOLOGIC PHENOTYPE OF ARID2-MEDIATED MYELODYSPLASTIC SYNDROMES.

EHA Library, Hideki Makishima, 181407

LOW MYBL2 EXPRESSION OBSERVED IN MYELODYSPLASTIC SYNDROME PATIENTS WITH WORSE PROGNOSIS IS ASSOCIATED WITH ALTERED DNA REPAIR MECHANISMS IN HAEMATOPOETIC STEM CELLS

EHA Library, Paloma Garcia, 181406

FBXW7 MUTATIONS LEAD TO ACCUMULATION OF NOTCH1, HIF1-ΑLPHA AND C-MYC IN CLL CELLS

EHA Library, Viola Meyer-Pannwitt, 181403

FUNCTIONAL PROTEOMICS IDENTIFIES SETD2 AS A CRITICAL EFFECTOR OF MLL FUSION PROTEINS TO SAFEGUARD GENOMIC INTEGRITY.

EHA Library, Anna Skucha, 181420

CEBPA-MUTANT ACUTE MYELOID LEUKEMIA IS SENSITIVE TO SMALL-MOLECULE-MEDIATED INHIBITION OF THE MENIN-MLL INTERACTION

EHA Library, Luisa Schmidt, 181421

CLINICAL IMPACT OF THE SUBCLONAL ARCHITECTURE AND MUTATIONAL COMPLEXITY IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ferran Nadeu, 181402

RISK-ADAPTED, MRD-DIRECTED THERAPY FOR YOUNG ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF THE AML1310 TRIAL OF THE GIMEMA GROUP

EHA Library, Adriano Venditti, 181398

STEP-WISE REPROGRAMMING OF ENDOTHELIAL CELLS INTO IMMUNE-COMPETENT HEMATOPOIETIC STEM CELLS

EHA Library, Jose Gabriel Barcia Duran, 181424

MARROW MESENCHYMAL STEM CELLS RESCUE BONE MARROW ENDOTHELIAL CELLS SUFFERING CHEMOTHERAPY STRESS BY TRANSFERRING MITOCHONDRIA THROUGH NANOTUBES

EHA Library, Yonghuai Feng, 181425

DEEP MOLECULAR RESPONSE TO GILTERITINIB IMPROVES SURVIVAL IN FLT3 MUTATION-POSITIVE RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Altman Jessica, 181397

POLA-R-CHP: POLATUZUMAB VEDOTIN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, H Tilly, 181393

WILMS' TUMOR 1 (WT1) RNA-ELECTROPORATED DENDRITIC CELL VACCINATION AS POST-REMISSION TREATMENT TO PREVENT OR DELAY RELAPSE IN ACUTE MYELOID LEUKEMIA: FINAL RESULTS OF A PHASE II STUDY IN 30 PATIENTS

EHA Library, ZN Berneman, 181428

FIRST-IN-HUMAN MULTICENTER STUDY OF BB2121 ANTI-BCMA CAR T CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS

EHA Library, Yi Lin, 181429

RITUXIMAB MAINTENANCE AFTER AUTOLOGOUS TEM CELL TRANSPLANTATION PROLONGS SURVIVAL IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: FINAL RESULTS OF THE LYMA TRIAL OF THE LYSA/GOELAMS GROUP

EHA Library, Steven Le, 181392

EFFICACY BY CYTOGENETIC RISK STATUS FOR DARATUMUMAB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE OR BORTEZOMIB AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Jesús San Miguel, 181388

NEXT GENERATION SEQUENCING (NGS) METHODOLOGY FOR DETERMINING CYTOGENETIC RISK STATUS IN THE DARATUMUMAB PHASE 3 CASTOR AND POLLUX STUDIES IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Christopher Chiu, 181387

Updates in the frontline setting and relapse MM from IMW 2017: An expert roundtable discussion

EHA Library, Delivered by Janssen, 183453

Car-T cells in AML

EHA Library, Attilio Bondanza, 192911

All children with sickle cell anemia and an HLA identical sibling should be offered hematopoietic stem cell transplantation

EHA Library, Mariane de Montalembert, 192914

Is transplantation still needed in the era of immunotherapy?

EHA Library, Anna Sureda, 184415

Clonal Evolution in AML

EHA Library, Klaus Metzeler, 192901

RBC hydration defects

EHA Library, Carlo Brugnara, 184429

Immunosenescence: When And How To Vaccinate Older Patients With Malignant Hemopathies?

EHA Library, Raphael Solana, 184422

Harnessing T-cell mediated anti-leukemic effect: From unmanipulated donor T-cells to tumor-specific and  genetically modified T-cells

EHA Library, Hans-Jochem Kolb, 184419

Engineering NK cells for the treatment of hematologic malignancies

EHA Library, Katy Rezvani, 184425

Immune checkpoint inhibitors

EHA Library, Anas Younes, 184414

Stomatocytosis and allied disorders

EHA Library, Immacolata Andolfo, 184428

Immunosenescence Or Why Are Older Patients More Sensitive To Malignancies?

EHA Library, Tamas Fulop, 184421

The long journey of donor search: From sibling to MUD to cord and haplo transplantation

EHA Library, Eliane Gluckman, 184418

Novel aspects of diagnosis of VT

EHA Library, Menno Huisman, 192909

RBC membrane transport in health and disease

EHA Library, Giel Bosman, 184427

Functional diversification of human NK cells

EHA Library, Kalle Malmberg, 184424

Elderly task force in hematology: Chair

EHA Library, Dominique BRON, 184420

Microenvironment in lymphoma

EHA Library, Georg Lenz, 184413

From dogs to humans... The 60 year long road of allogeneic stem cell transplantation

EHA Library, Rainer Storb, 184417

PEG Filgrastim in SCN

EHA Library, Francesca Fioredda, 184410

Emerging treatments for classical myeloproliferative neoplasms

EHA Library, Claire Harrison, 184398

Treatment of extranodal marginal zone B-cell lymphomas

EHA Library, Markus Raderer, 184394

The 100.000 genomes project

EHA Library, Willem Ouwehand, 184406

Top 3 AML

EHA Library, Gert Ossenkoppele, 192944

PET-CT as biomarker for response in Lymphoma?/ Interim-PET as a valid biomarker for early response in malignant lymphoma; when to perform and how to assess

EHA Library, Josee Zijlstra, 192943

Although ALL is highly curable with conventional chemotherapy, novel therapeutic approaches are still needed to improve outcomes for high-risk or relapsed ALL, especially in adults.Immunotherapeutic approaches have significantly improved the outcome of R

EHA Library, Josep-Maria Ribera, 184402

Diagnosis and management of rare bleeding disorders & gene therapy

EHA Library, Gili Kenet, 192942

Neurological complications of sickle cell disease

EHA Library, Fenalla Kirkham, 192941

Highlights in ALL

EHA Library, Ajay Vora, 192940

Highlights in MPN

EHA Library, Claire Harrison, 192939

Stop of TKI in CML

EHA Library, Juan Luis Steegmann, 192938

Should low risk MDS be transplanted?

EHA Library, Nicolaus Kröger, 192937

The long journey of donor search: From sibling to MUD to cord and haplo transplantation

EHA Library, Eliane Gluckman, 192936

RBC membrane transport in health and disease

EHA Library, Giel Bosman, 192935

Diagnosis and management of Von Willebrand Disease

EHA Library, Giancarlo Castaman, 192934

First-line therapy for CLL in 2017

EHA Library, Alessandra Tedeschi, 192933

Treatment should be started in every patient with high risk smoldering multiple myeloma

EHA Library, Maria Victoria Mateos, 192932

Treatment and sequence in multiple myeloma

EHA Library, Xavier Leleu, 192931

Anticoagulation in the frail patient / Anticoagulation in the elderly/frail patient (25min)

EHA Library, Kamphuisen Pieter, 192945

Neutrophil extra cellular traps (NET)

EHA Library, Jean Donadieu, 184409

Update on follicular lymphoma: Time beyond chemotherapy?

EHA Library, Kai Hübel, 184393

Targeting specific mutations in MPN

EHA Library, Ann Mullally, 184397

Immunotherapy of ALL from biology to the clinic and back

EHA Library, Terry Fry, 184401

Syndromes predisposing to hematological malignancies

EHA Library, Christian Kratz, 184405

Drivers of leukemogenesis in congenital neutropenias

EHA Library, Karl Welte, 184408

Molecular profiling of indolent lymphoma

EHA Library, Stefano Pileri, 184392

Molecular genetics in MPN

EHA Library, Alessandro M. Vannucchi, 184396

Balance of efficacy vs toxicity in treatment of childhood ALL: Time for dose reductions?

EHA Library, Ajay Vora, 184400

Diagnosis of inherited bone marrow failure and myelodysplastic syndromes

EHA Library, Akiko Shimamura, 184404

EHA22 Educational Updates in Hematology

EHA Library, EHA annual congress, 186248

Is transplantation in lymphoma still needed in the era of immunotherapy?

EHA Library, Anna Sureda, 185024

Immune checkpoint inhibitors

EHA Library, Anas Younes, 185023

The role of the microenvironment in the pathogenesis of B-cell lymphomas

EHA Library, Georg Lenz, 185022

The 100.000 Genomes Project

EHA Library, Willem Ouwehand, 185021

Diagnosis of inherited bone marrow failure and myelodysplastic syndromes

EHA Library, Akiko Shimamura, 185020

Syndromes predisposing to hematological malignancies

EHA Library, Christian Kratz, 185019